Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. This position is responsible for the quarterly global consolidation, supporting both external reporting and internal management financial reporting for a collaboration program. This position has responsibilities of working closely with various functions within the company and acting as a liaison with the external partner for a smooth consolidation process. Also responsible for managing various studies including late-stage budget and forecasting, analysis, strategic planning, internal reporting, and ad hoc reporting and analysis.
A Smarter and Faster Way to Build Your Resume